Haemonetics upgraded at BofA on conservative outlook
2026-05-22 13:29:40 ET
More on Haemonetics
- Haemonetics Corporation (HAE) Presents at Bank of America Global Healthcare Conference 2026 Transcript
- Haemonetics Corporation 2026 Q4 - Results - Earnings Call Presentation
- Haemonetics Corporation (HAE) Q4 2026 Earnings Call Transcript
- Haemonetics projects FY 2027 revenue growth of 4% to 7% as Persona PLUS rollout and IVT rebound efforts continue
- Haemonetics Q4 2026 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Haemonetics upgraded at BofA on conservative outlookNASDAQ: HAE
HAE Trading
3.69% G/L:
$71.435 Last:
243,692 Volume:
$70.10 Open:



